Cargando…
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
Altered glycosylation is a common feature of cancer cells. It takes a variety of forms, which includes loss of expression or excessive expression of some structures, the accumulation of precursors, the appearance of novel structures, etc. Notably, these changes in glycan structure do not occur as a...
Autores principales: | Lu, Jishun, Gu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272632/ https://www.ncbi.nlm.nih.gov/pubmed/25919275 http://dx.doi.org/10.3390/molecules20057509 |
Ejemplares similares
-
The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation
por: Zhou, Leqi, et al.
Publicado: (2019) -
Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructose-responsive manner promotes pancreatic cancer metastasis
por: Hsieh, Chi-Che, et al.
Publicado: (2016) -
Sialylation by β-galactoside α-2,6-sialyltransferase and N-glycans regulate cell adhesion and invasion in human anaplastic large cell lymphoma
por: SUZUKI, OSAMU, et al.
Publicado: (2015) -
Methyl 6-azido-6-deoxy-α-d-galactoside
por: Cheng, Janice M. H., et al.
Publicado: (2011) -
Methyl 6-deoxy-6-iodo-α-d-galactoside
por: Gulab, Shivali A., et al.
Publicado: (2010)